Biotech Acquisition (OTCMKTS:BIOTU – Get Free Report) shares traded down 7.7% on Thursday . The company traded as low as $10.14 and last traded at $10.14. 1,300 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 4,444 shares. The stock had previously closed at $10.98.
Biotech Acquisition Stock Performance
The firm’s 50-day simple moving average is $10.14 and its 200-day simple moving average is $10.14.
Biotech Acquisition Company Profile
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Further Reading
- Five stocks we like better than Biotech Acquisition
- The 3 Best Fintech Stocks to Buy Now
- MarketBeat Week in Review – 03/24 – 03/28
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
